Paper Title Theme Presentation Type Poster Presentatio n Day

Size: px
Start display at page:

Download "Paper Title Theme Presentation Type Poster Presentatio n Day"

Transcription

1 A NOVEL PROBE OF FUNCTIONAL NETWORK ARCHITECTURE IN PROTEINOPATHIES: SPECTRAL DCM IN SEMANTIC DEMENTIA Blood and imaging biomarkers Poster and Data Blitz Monday 1 M1 PATHWAYS PREDICTION & RISK-GENE PRIORITIZATION BY PROTEIN-PROTEIN INTERACTION NETWORK ANALYSIS OF FTD GENES Bioinformatics Poster and Data Blitz Monday 2 M2 PROFILING THE AUTOANTIBODY REPERTOIRE IN FTD AND ALS Blood and imaging biomarkers Poster and Data Blitz Monday 3 M3 INDIVIDUALIZING DISEASE PREDICTION ACROSS MULTIPLE FTLD SYNDROMES BY VOLUMETRIC MRI ANALYSIS & MACHINE LEARNING Blood and imaging biomarkers Poster and Data Blitz Monday 4 M4 BIG DATA TECHNOLOGIES ENABLES DISTANT RELATIONSHIP AND DISEASE VARIANT DISCOVERY IN ALS Bioinformatics Poster and Data Blitz Monday 5 M5 MUTATIONS IN PROGRANULIN CAUSE DYSREGULATION OF CERAMIDE LEVELS Mechanisms of cell death Poster and Data Blitz Monday 6 M6 CHEMICAL SUPPRESSION OF GRN NONSENSE MUTATIONS INCREASES PROGRANULIN IN PRECLINICAL MODELS OF FRONTOTEMPORAL DEMENTIA Treatment (pharmacological / non-pharmacological) Poster and Data Blitz Monday 8 M7 Peripheral Innate Immune Activation Correlates with Disease Severity in GRN Haploinsufficiency Blood and imaging biomarkers Poster and Data Blitz Monday 8 M8 EARLY AND DISTINCT PERFUSION ALTERATIONS IN PRESYMPTOMATIC MAPT, GRN AND C9ORF72 MUTATION CARRIERS. Blood and imaging biomarkers Poster and Data Blitz Monday 9 M9 TRAJECTORIES OF NEURODEGENERATION IN THE PRESYMPTOMATIC STAGE OF GENETIC FRONTOTEMPORAL DEMENTIA A LONGITUDINAL MRI STUDY Blood and imaging biomarkers Poster and Data Blitz Monday 10 M10 FUS aggregation is associated with microrna and gene expression modifications in FTLD brain tissues. Genetics Poster and Data Blitz Monday 11 M11 ACCELERATED NEUROCHEMICAL CHANGES PRIOR TO PHENOCONVERSION TO OVERT FTLD IN PRESYMPTOMATIC MAPT MUTATION CARRIERS: A LONGITUDINAL MRS STUDY Blood and imaging biomarkers Poster and Data Blitz Monday 12 M12 BEST PRACTICES FOR GENETIC COUNSELING AND TESTING FOR ALZHEIMER S DISEASE AND FRONTOTEMPORAL DEMENTIA SINCE THE ADVENT OF NEXT GENERATION Genetics Poster and Data Blitz Monday 13 M13 SEQUENCING GENETIC POLYMORPHISMS ASSOCIATED WITH COGNITION AND BEHAVIOR IN SPORADIC ALS Bioinformatics Poster and Data Blitz Monday 14 M14 CEREBRAL BLOOD FLOW IN REGIONS SHOWING PRE-SYMPTOMATIC HYPOPERFUSION IS ASSOCIATED WITH MEMORY AND ORIENTATION IMPAIRMENTS A GENFI Blood and imaging biomarkers Poster and Data Blitz Monday 15 M15 STUDY MULTIPPA: PROSPECTIVE MULTICENTER STUDY ON MULTILINGUALISM IN PRIMARY PROGRESSIVE APHASIA Progressive aphasias Poster and Data Blitz Monday 16 M16 THE EFFECT OF STEREOTYPIC BEHAVIOR ON FTLD PATIENTS AND THEIR CAREGIVERS Social cognition and behavior Poster and Data Blitz Monday 17 M17 18F-FDG PET/CT HYPOMETABOLISM PATTERNS CONTRIBUTES TO CHARACTERIZE bvftd IN A HETEROGENEOUS PHENOTYPIC SPECTRUM. A MEXICAN CASUISTIC. Blood and imaging biomarkers Poster and Data Blitz Monday 18 M18 THE FTD DISORDERS REGISTRY: A CONTACT AND RESEARCH REGISTRY TO GIVE VOICE TO THE PATIENT/CAREGIVER COMMUNITY AND ADVANCE THE SCIENCE OF FTD Bioinformatics Poster and Data Blitz Monday 19 M19 RESEARCH Apathy and its impact on carer burden and wellbeing in primary progressive aphasias Caregiver Poster and Data Blitz Monday 20 M20 FUNCTIONAL LANGUAGE NETWORKS IN PRIMARY PROGRESSIVE APHASIA Progressive aphasias Poster and Data Blitz Monday 21 M21 Altered connectivity of the dorsal attention network in semantic dementia Progressive aphasias Poster and Data Blitz Monday 22 M22 LOST FOR WORDS? EVIDENCE FOR PERVASIVE SOCIAL COMMUNICATION DYSFUNCTION ACROSS THE FRONTOTEMPORAL LOBAR DEGENERATION SPECTRUM Social cognition and behavior Poster and Data Blitz Monday 23 M23 4tDCS effeciency for anomia affected by FTD sub-type Treatment (pharmacological / non-pharmacological) Poster and Data Blitz Monday 24 M24 MYWORDTRAINER A USABILITY PILOT STUDY FOR APP-BASED WORD RETRAINING IN SEMANTIC VARIANT PRIMARY PROGRESSIVE APHASIA Progressive aphasias Poster and Data Blitz Monday 25 M25 Alteration of Neuroinflammatory Mediators Relative to Tau and Neuron Specific Enolase in Frontotemporal Dementia Compared to Alzheimer s Disease Bioinformatics Poster Monday 26 M26 MEG MODELLING GABA-ERGIC EFFECTS IN FRONTOTEMPORAL NETWORKS Neuropathology Poster Monday 27 M27 CLINICOPATHOLOGICAL CORRELATIONS IN A FAMILY WITH A TBK1 MUTATION PRESENTING AS PRIMARY PROGRESSIVE APHASIA AND PRIMARY LATERAL SCLEROSIS Neuropathology Poster Monday 28 M28 Planned study: Learning effects of repeated neuropsychological examination among frontotemporal dementia mutation carriers and non-carriers Genetics Poster Monday 29 M29 Interrupted CAG repeats in ATXN2 gene a new player in the genetic spectrum of FTD Genetics Poster Monday 30 M30 DIFFERENT RATES OF LOBAR ATROPHY BETWEEN SYMPTOMATIC AND ASYMPTOMATIC MAPT MUTATION CARRIERS: PRELIMINARY DATA FROM THE LEFFTDS Blood and imaging biomarkers Poster Monday 31 M31 CONSORTIUM Von Economo and Fork Cells from Anterior Insula Project to the Amygdala Neuropathology Poster Monday 32 M32 Non-dominant Hemisphere Network Alterations in Primary Progressive Aphasia: Evidence for Potential Neuroplasticity Using Resting State Functional Connectivity Progressive aphasias Poster Monday 33 M33 Preliminary Results on Treatment-induced Changes in Resting Brain Activity in Primary Progressive Aphasia Progressive aphasias Poster Monday 34 M34 Executive functioning in primary progressive AOS and agrammatic PPA with and without AOS Progressive aphasias Poster Monday 35 M35 Atrophy of Gyrus Rectus and Superior Frontal Gyrus are Associated with Behavioral Problems in Dementia Blood and imaging biomarkers Poster Monday 36 M36 RELATIVE EFFECTS OF COGNITIVE AND BEHAVIORAL DYSFUNCTION ON ABNORMAL FEEDING IN BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA Social cognition and behavior Poster Monday 37 M37 ENTORHINAL CORTEX DIFFUSION MRI ABNORMALITIES IN ASYMPTOMATIC AND SYMPTOMATIC MAPT MUTATION CARRIERS Blood and imaging biomarkers Poster Monday 38 M38 FRONTAL LOBE 1H MR SPECTROSCOPY IN ASYMPTOMATIC AND SYMPTOMATIC MAPT MUTATION CARRIERS Blood and imaging biomarkers Poster Monday 39 M39 Long-term word retrieval treatment in nonfluent-agrammatic primary progressive aphasia supports conversation in a semi-structured interview: A single case study Progressive aphasias Poster Monday 40 M40

2 DISTINCT ERRORS IN CONNECTED SPEECH PRODUCTION IN ENGLISH AND ITALIAN SPEAKERS WITH NON-FLUENT VARIANT PRIMARY PROGRESSIVE APHASIA Progressive aphasias Poster Monday 41 M41 Relating brain volume loss to histopathological surrogate biomarkers in frontotemporal lobar degeneration Blood and imaging biomarkers Poster Monday 42 M42 MOTOR FEATURES IN PATIENTS IN FAMILIAL FRONTOTEMPORAL LOBAR DEGENERATION INVOLVING MUTATIONS IN THE GENES ENCODING MAPT, GRN OR Genetics Poster Monday 43 M43 C9ORF72: LEFFTDS PROTOCOL PSYCHOSIS AND ABNORMAL PERCEPTUAL EXPERIENCES ACROSS THE FTD-MND SPECTRUM Social cognition and behavior Poster Monday 44 M44 Primary Progressive Aphasia viewed through the lens of the ATN framework Blood and imaging biomarkers Poster Monday 45 M45 PREDICTION OF BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA DEVELOPMENT USING MULTIVARIATE PATTERN ANALYSIS OF MAGNETIC RESONANCE Blood and imaging biomarkers Poster Monday 46 M46 IMAGING DATA Secondary mania as a possible presentation of a C9orf72 hexanucleotide repeat expansion. Genetics Poster Monday 47 M47 GENETIC COUNSELLING IN FTD: BENEFITS, CHALLENGES AND FUTURE DIRECTIONS Genetics Poster Monday 48 M48 PATTERN AND FREQUENCY OF COGNITIVE IMPAIRMENT IN INDIVIDUALS IN THE LEFFTDS COHORT WHO PHENOCONVERTED FROM CLINICALLY NORMAL TO Social cognition and behavior Poster Monday 49 M49 SYMPTOMATIC FTLD Developing novel CSF Biomarkers for Tauopathies Neuropathology Poster Monday 50 M50 UNRAVELLING ASTROCYTIC PATHOLOGY IN FRONTOTEMPORAL LOBAR DEGENERATION Neuropathology Poster Monday 51 M51 Single-cell transcriptomic characterization of peripheral immune dysfunction in progranulin haploinsufficient frontotemporal lobar degeneration Genetics Poster Monday 52 M52 Clinical Assessments to Differentiate FTD and AD Pathology in Patients that Meet bvftd Criteria Neuropathology Poster Monday 53 M53 Conceptualisation difficulties in primary progressive aphasia: What evidence can be gained from a Cookie Theft picture description? Progressive aphasias Poster Monday 54 M54 A diagnostic 'roadmap' for primary progressive aphasia: validation in a large, intensively phenotyped cohort Progressive aphasias Poster Monday 55 M55 Reduced sensitivity to delayed auditory feedback in nonfluent variant primary progressive aphasia Progressive aphasias Poster Monday 56 M56 A NOVEL VARIANT IN MAPT GENE IN FRONTOTEMPORAL DEMENTIA Genetics Poster Monday 57 M57 Plasma GFAP levels are increased in symptomatic FTD mutation carriers within the GENFI cohort Blood and imaging biomarkers Poster Monday 58 M58 The impact of behavioural symptoms across neurodegenerative brain conditions Social cognition and behavior Poster Monday 59 M59 The modified Neuropsychiatric Inventory (mnpi) in the FTD Spectrum Social cognition and behavior Poster Monday 60 M60 NEUROPSYCHIATRIC PROFILES OF FRONTOTEMPORAL DEGENERATION SUBTYPES FROM THE NEUROIMAGING IN FRONTOTEMPORAL DEMENTIA (NIFD) STUDY Social cognition and behavior Poster Monday 61 M61 NONLINEAR Z-SCORE ESTIMATION FOR ESTABLISHING COGNITIVE NORMS FROM THE NATIONAL ALZHEIMER S COORDINATING (NACC) DATASET FOR ARTFL/LEFFTDS Social cognition and behavior Poster Monday 62 M62 Deciphering the clinical phenotype of argyrophilic grain disease: a clinicopathological study Neuropathology Poster Monday 63 M63 Middle and Inferior Longitudinal Fascicle involvement in the Logopenic Variant of Primary Progressive Aphasia. Progressive aphasias Poster Monday 64 M64 Semantic Impairment in the Logopenic Variant of Primary Progressive Aphasia Progressive aphasias Poster Monday 65 M65 Neural Correlates of Impaired Naming in Non-Semantic Variants Converge Over Time Progressive aphasias Poster Monday 66 M66 SOCIAL COGNITION DIFFERENTIATES BEHAVIORAL-VARIANT FRONTOTEMPORAL DEMENTIA FROM DEPRESSION AND HEALTHY CONTROLS Social cognition and behavior Poster Monday 67 M67 SELECTIVE REGIONAL AND NEURONAL TAU AGGREGRATION IN FRONTOTEMPORAL LOBAR DEGENERATION WITH MAPT VARIANTS Neuropathology Poster Monday 68 M68 MR-less surface-based [18F]-FDG PET imaging differentiates Frontotemporal Dementia from Alzheimer s disease Blood and imaging biomarkers Poster Monday 69 M69 DISEASE-ASSOCIATED LEVELS OF NEUROFILAMENT MEDIUM IN CSF FROM PATIENTS WITH FRONTOTEMPORAL DEMENTIA Blood and imaging biomarkers Poster Monday 70 M70 CAUSES OF CLINICAL MISDIAGNOSIS IN FRONTOTEMPORAL LOBAR DEGENERATION: A CLINICOPATHOLOGICAL STUDY Neuropathology Poster Monday 71 M71 BRIDGING PHENOMENOLOGY AND NEUROSCIENCE: INTEROCEPTION AND SEMANTIC KNOWLEDGE IN SEMANTIC DEMENTIA PATIENTS Blood and imaging biomarkers Poster Monday 72 M72 GENETIC PATHOGENIC VARIANTS ASSOCIATED WITH FTD IN COLOMBIA Genetics Poster Monday 73 M73 GENETIC DIAGNOSTIC TOOLS FOR FRONTOTEMPORAL DEMENTIA IN A COLOMBIAN COHORT Genetics Poster Monday 74 M74 SYSTEMATIC EVALUATION OF GRAY MATTER CHANGES ON 42 POLYMORPHISMS IN FTLD COLOMBIAN PATIENTS Blood and imaging biomarkers Poster Monday 75 M75 NEUROPSYCHIATRIC SYMPTOMS AND SOCIAL BEHAVIOR IN FRONTOTEMPORAL DEMENTIA IN COLOMBIA Social cognition and behavior Poster Monday 76 M76 BASELINE & LONGITUDINAL VOLUMETRIC CHANGES ASSOCIATED WITH PRESYMPTOMATIC C9ORF72 REPEAT EXPANSION CARRIERS Blood and imaging biomarkers Poster Monday 77 M77 NEUROANATOMICAL CORRELATES OF RETINAL THINNING IN FTD Blood and imaging biomarkers Poster Monday 78 M78 Neuropathological study of acase of FTLD- SD- TDP43, the first case of our twenty year experience of brain banking Neuropathology Poster Monday 79 M79 METABOLIC PATHWAY ALTERATIONS IN FRONTOTEMPORAL LOBAR DEGENERATION SYNDROMES Blood and imaging biomarkers Poster Monday 80 M80 PROTON MAGNETIC RESONANCE SPECTROSCOPY IN FRONTOTEMPORAL LOBAR DEGENERATION SYNDROMES Blood and imaging biomarkers Poster Monday 81 M81 Does IQ influence cognitive performance in presymptomatic mutation carriers in genetic FTD? Genetics Poster Monday 82 M82 Right temporal lobe degeneration: Cognitive and 18F AV1451 imaging phenotypes Blood and imaging biomarkers Poster Monday 83 M83 Predicting the stability of a frontotemporal dementia diagnosis Bioinformatics Poster Monday 84 M84

3 NEUROPSYCHOLOGICAL PROFILES IN GENETIC FRONTOTEMPORAL DEMENTIA Social cognition and behavior Poster Monday 85 M85 TMEM106B HAPLOTYPES HAVE DISTINCT GENE EXPRESSION PATTERNS IN AGED BRAIN Bioinformatics Poster Monday 86 M86 THE BIOLOGICAL FUNCTIONALITY OF GENETIC VARIANTS IN FRONTOTEMPORAL DEMENTIA Genetics Poster Monday 87 M87 Quantifying decline at clinically relevant time intervals in the Aphasic Variant of Alzheimer s disease Progressive aphasias Poster Monday 88 M88 Baseline cognitive data within the Longitudinal Evaluation of Familial Frontotemporal Dementia (LEFFTDs) cohort Social cognition and behavior Poster Monday 89 M89 Social cognitive impairment in familial frontotemporal dementia: results from the GENFI study Social cognition and behavior Poster Monday 90 M90 Early biomarkers of frontotemporal dementia: The New Zealand Genetic FTD Study (FTDGeNZ) Blood and imaging biomarkers Poster Monday 91 M91 TASTE PREFERENCES IN SEMANTIC DEMENTIA AND ALZHEIMER S DISEASE Social cognition and behavior Poster Monday 92 M92 THE CLINICAL VALUE OF SERUM NEUROFILAMENT LIGHT CHAIN IN THE SPECTRUM OF PRIMARY PROGRESSIVE APHASIA Progressive aphasias Poster Monday 93 M93 NOVEL P397S MAPT MUTATION CAUSING LATE ONSET SLOW PROGRESSIVE FRONTOTEMPORAL DEMENTIA Genetics Poster Monday 94 M94 DOES ALS-FUS WITHOUT FUS MUTATION REPRESENT ALS-FET COUNTERPART OF FTLD-FET? Neuropathology Poster Monday 95 M95 CLINICAL AND NEUROPATHOLOGIC ANALYSIS OF 67-YEAR-OLD JAPANESE FTLD-ALS MALE WITH C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSION. A SECOND AUTOPSY Neuropathology Poster Monday 96 M96 CASE IN JAPAN. SEX DIFFERENCES IN BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN FRONTOTEMPORAL DEMENTIA Social cognition and behavior Poster Monday 97 M97 THE NEURAL BASIS OF METACOGNITION IN FRONTO-INSULAR STROKE AND NEURODEGENERATIVE DISEASES Social cognition and behavior Poster Monday 98 M98 ENVY AND SCHADENFREUDE: LEGAL, DESERVINGNESS AND MORAL DIMENSIONS IN FRONTOTEMPORAL DEMENTIA Social cognition and behavior Poster Monday 99 M99 NEUROANAMTOMICAL CORRELATES OF EXECUTIVE DIMENSIONS IN THE BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA Social cognition and behavior Poster Monday 100 M100 FREQUENCY OF SUICIDE IN SYMPTOMATIC PATIENTS WITH FRONTOTEMPORAL DEMENTIAS AND HUNTINGTON DISEASE: ANALYSIS OF FAMILY-REPORTED PEDIGREE Genetics Poster Monday 101 M101 DATA Two pathologically-confirmed cases of novel mutations in the MAPT gene causing behavioural variant frontotemporal dementia Genetics Poster Monday 102 M102 Development of a multiplex digital immunoassay for detection of Neurofilament-Light, Tau, Glial Fibrillary Acidic Protein and Ubiquitin c-terminal Hydrolase L1 in blood Blood and imaging biomarkers Poster Monday 103 M103 and cerebrospinal fluid Laughter: a novel probe of socio-emotional pathophysiology in FTD Social cognition and behavior Poster Monday 104 M104 LONGITUDINAL MULTIMODAL NEUROIMAGING AND CLINICAL ENDPOINTS FOR FRONTOTEMPORAL DEMENTIA CLINICAL TRIALS Blood and imaging biomarkers Poster Monday 105 M105 Size mosaicism of C9orf72 repeat expansion allele is more common in frontotemporal degeneration than in amyotrophic lateral sclerosis Genetics Poster Monday 106 M106 Atypical Huntington s Disease with the Clinical n of Behavioural Variant of Frontotemporal Dementia Neuropathology Poster Monday 107 M107 11C-PBB3 TAU IMAGING IN LOGOPENIC VARIANT PRIMARY PROGRESSIVE APHASIA Blood and imaging biomarkers Poster Monday 108 M108 Multiple neuronal pathologies are common in young patients with pathologically proven Frontotemporal lobar degeneration Neuropathology Poster Monday 109 M109 EVALUATING THE BENEFITS OF GROUP INTERVENTION FOR PEOPLE WITH PRIMARY PROGRESSIVE APHASIA AND THEIR CAREGIVERS. Progressive aphasias Poster Monday 110 M110 FACTORS CONTRIBUTING TO ADHERENCE TO LEXICAL RETRIEVAL TREATMENT IN PRIMARY PROGRESSIVE APHASIA Progressive aphasias Poster Monday 111 M111 Use of a novel Cantonese speech and language battery for the diagnosis of non-fluent variant primary progressive aphasia in a multilingual speaker. Progressive aphasias Poster Monday 112 M112 DIFFERENT PATTERNS OF CHANGE IN WARMTH ARE REFLECTED IN SALIENCE NETWORK CONNECTIVITY IN FRONTOTEMPORAL DEMENTIA SYNDROMES Social cognition and behavior Poster Monday 113 M113 Shared neurobiology of frontotemporal dementia and music perception Social cognition and behavior Poster Monday 114 M114 Musical syndromes and music emotion recognition in patients with frontotemporal dementia Social cognition and behavior Poster Monday 115 M115 Atypical Forms Of Alzheimer s Disease Causing FTLD Spectrum Clinical Phenotypes Are Less Susceptible to ApoE4 Neuropathology Poster Monday 116 M116 Mean pause length in spontaneous speech discriminates Primary Progressive Aphasia variants across languages Progressive aphasias Poster Monday 117 M117 Automatic extraction of a reference region for the noninvasive quantification of 11C-PBR28: application to patients with dementia Bioinformatics Poster Monday 118 M118 FRONTO-TEMPORAL DEMENTIA AND CORTICOBASAL SYNDROME: CASE STUDIES OF OVERLAPPING PHENOTYPES CBS, PSP, MND Poster Monday 119 M119 SUPPRESSION OF CONDITIONAL TDP-43 TRANSGENE EXPRESSION DIFFERENTIALLY AFFECTS EARLY COGNITIVE AND SOCIAL PHENOTYPES IN TDP-43 MICE Social cognition and behavior Poster and Data Blitz Tuesday 1 T1 SM07883, A NOVEL, POTENT, AND SELECTIVE ORAL DYRK1A INHIBITOR REDUCED TAU PATHOLOGY IN PRECLINICAL MODELS Treatment (pharmacological / non-pharmacological) Poster and Data Blitz Tuesday 2 T2 Ursadeoxycholic acid reduces memory impairments and phosphorylated tau pathology in a murine model of FTDP-17 Treatment (pharmacological / non-pharmacological) Poster and Data Blitz Tuesday 4 T4 Body composition in frontotemporal dementia: Where reward interacts with physiological functioning Social cognition and behavior Poster and Data Blitz Tuesday 5 T5 Co-localisation of neuroinflammation and protein aggregation across the frontotemporal dementia spectrum Blood and imaging biomarkers Poster and Data Blitz Tuesday 6 T6 CEREBELLAR WHITE MATTER CHANGES AND THEIR CONTRIBUTIONS TO COGNITIVE DYSFUNCTION IN FRONTOTEMPORAL DEMENTIAS Social cognition and behavior Poster and Data Blitz Tuesday 7 T7 COGNITIVE, BEHAVIOURAL AND STRUCTURAL BRAIN CHANGES IN NON-PROGRESSIVE BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA Blood and imaging biomarkers Poster and Data Blitz Tuesday 8 T8 Reduced BOLD signal in anterior cingulate cortex and anterior insula in behavioral variant frontotemporal dementia when viewing images of hands in painful situations Blood and imaging biomarkers Poster and Data Blitz Tuesday 9 T9 Does TDP-43 pathology cause axon traffic problems? Neuropathology Poster and Data Blitz Tuesday 10 T10 Novel neuronal intranuclear inclusion disease subtype with frontotemporal dementia-like features Neuropathology Poster and Data Blitz Tuesday 11 T11

4 QUANTIFICATION OF NEURONS IN INFERIOR FRONTAL GYRUS IN PATIENTS WITH FRONTOTEMPORAL LOBAR DEGENERATION Neuropathology Poster and Data Blitz Tuesday 12 T12 Primary age related tauopathy (PART) is important pathology of supercentenarian brains Neuropathology Poster and Data Blitz Tuesday 13 T13 Distinct TDP-43 inclusion morphologies in FTLD and FTLD-ALS contest the theory of a disease continuum Neuropathology Poster and Data Blitz Tuesday 14 T14 CHARACTERISTICS OF FRONTOTEMPORAL DEMENTIA PATIENTS CAREGIVERS Caregiver Poster Tuesday 15 T15 Advancing Clinical and Biomarker Research in AD: The LEAD Study Blood and imaging biomarkers Poster Tuesday 16 T16 Understanding the Lived Experience of the Frontotemporal Dementia Family Caregiver Caregiver Poster Tuesday 17 T17 The Eating Behavior Inventory (EBI): a 30-item questionnaire helping to distinguish frontotemporal dementia from bipolar disorder and Alzheimer disease. Social cognition and behavior Poster Tuesday 18 T18 MUSIC EVOKED AUTOBIOGRAPHICAL MEMORIES IN PEOPLE WITH BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA: PLAY IT AGAIN SAM! Caregiver Poster Tuesday 19 T19 Relations between blood repeat expansion size, age at onset, age at collection, and phenotype in C9orf72 carriers. Blood and imaging biomarkers Poster Tuesday 20 T20 FIVE CASES OF SEMANTIC PROGRESSIVE APHASIA, A DIAGNOSTIC CHALLENGE Progressive aphasias Poster Tuesday 21 T21 PHYSIOLOGICAL SIGNATURES OF MUSICAL MEMORY IN FRONTOTEMPORAL DEMENTIA AND ALZHEIMER S DISEASE Social cognition and behavior Poster Tuesday 22 T22 AUTONOMIC CODING OF FUNDAMENTAL SENSORY INFORMATION CONTENT IN FRONTOTEMPORAL DEMENTIAS Social cognition and behavior Poster Tuesday 23 T23 PHYSIOLOGICAL SIGNATURES OF SURPRISE IN FRONTOTEMPORAL DEMENTIAS: THE PARADIGM OF MUSIC Social cognition and behavior Poster Tuesday 24 T24 Amygdalar subnuclei are particularly affected in tau-mapt, tau-pick s disease and TDP-43 type C-associated frontotemporal dementia Blood and imaging biomarkers Poster Tuesday 25 T25 SELF SCHEMA ALTERATIONS IN FRONTOTEMPORAL DEMENTIAS AND ALZHEIMER S DISEASE Social cognition and behavior Poster Tuesday 26 T26 MULTI-DOMAIN REWARD VALUATION IN FRONTOTEMPORAL DEMENTIAS AND ALZHEIMER S DISEASE Social cognition and behavior Poster Tuesday 27 T27 TACTILE PROCESSING IN FRONTOTEMPORAL DEMENTIAS AND ALZHEIMER S DISEASE Social cognition and behavior Poster Tuesday 28 T28 Value of DAPHNE for diagnosis of Frontal variant of Alzheimer disease vs Frontal variant of Frontotemporal dementia Social cognition and behavior Poster Tuesday 29 T29 THE CLINICAL PROFILE OF FTLD IN NORTH AMERICA: BASELINE CHARACTERISTICS OF THE FIRST 1011 PARTICIPANTS FROM THE ADVANCING RESEARCH AND Treatment (pharmacological / non-pharmacological) Poster Tuesday 30 T30 TREATMENT FOR FRONTOTEMPORAL LOBAR DEGENERATION (ARTFL) CONSORTIUM A COMPARISON OF SPORADIC AND GENETIC FORMS OF BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA IN THE ADVANCING RESEARCH AND TREATMENT FOR Treatment (pharmacological / non-pharmacological) Poster Tuesday 31 T31 FRONTOTEMPORAL LOBAR DEGENERATION (ARTFL) CONSORTIUM Time to target neuroinflammation in Frontotemporal dementia (FTD): Assessing autoimmune disease and inflammation in the Forefront FTD cohort. Neuropathology Poster Tuesday 32 T32 Deep learning-based prediction of atrophy trajectories in individuals across the neurodegenerative spectrum Blood and imaging biomarkers Poster Tuesday 33 T33 NEUROPSYCHOLOGICAL PROFILES IN AUTOPSY-CONFIRMED CASES OF BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA AND ALZHEIMER S DISEASE Neuropathology Poster Tuesday 34 T34 ELEVATED ALS BIOMARKER LEVELS IN CSF OF A FTD PATIENT AT THE PRESYMPTOMATIC STAGE Blood and imaging biomarkers Poster Tuesday 35 T35 SOCIO-COGNITIVE AND EXECUTIVE DYSFUNCTION IN BEHAVIOURAL-VARIANT FRONTOTEMPORAL DEMENTIA: IMPLICATIONS FOR PATIENT CRIMINAL AND MORAL Social cognition and behavior Poster Tuesday 36 T36 RESPONSIBILITY CSF BIOMARKERS FOR FRONTOTEMPORAL DEMENTIA AND ITS PATHOLOGICAL SUBTYPES Blood and imaging biomarkers Poster Tuesday 37 T37 Clinicopathological correlations in frontotemporal dementia in the Dutch population Neuropathology Poster Tuesday 38 T38 Clinical guidance for pharmacological symptomatic interventions in behavioral variant frontotemporal dementia: A systematic review Treatment (pharmacological / non-pharmacological) Poster Tuesday 39 T39 A Computational Network Model for the Effects of Frontotemporal Dementia on Social Functioning. Social cognition and behavior Poster Tuesday 40 T40 THE VALUE OF NEUROPSYCHOLOGICAL ASSESSMENT IN THE DIFFERENTIATION OF BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA AND PRIMARY Social cognition and behavior Poster Tuesday 41 T41 PSYCHIATRIC DISORDERS IN PATIENTS PRESENTING WITH FRONTAL BEHAVIOURAL CHANGES SEX SPECIFIC REGULATION OF ANTERIOR CINGULATE GYRUS NEURAL NETWORK PROCESSING UNDERLIES GENDER DIFFERENCES IN SOCIAL INTELLIGENCE DECLINE Social cognition and behavior Poster Tuesday 42 T42 IN EMERGING BEHAVIORAL VARIANT FTD (BV FTD). Arginine methylation of poly-gr inclusions in C9orf72 FTD and ALS patient cortex do not correlate with clinical features Neuropathology Poster Tuesday 44 T44 Frontotemporal Dementia Carer Support Group - Learnings and ongoing achievements Caregiver Poster Tuesday 45 T45 COMPARING CLINICAL RATING SCALES IN GENETIC FRONTOTEMPORAL DEMENTIA WITHIN THE GENFI COHORT Social cognition and behavior Poster Tuesday 46 T46 Divergent inter-hemispheric patterns of TDP-43 and tau proteinopathies in primary progressive aphasia Progressive aphasias Poster Tuesday 47 T47 Improving clinical distinction of logopenic variant primary progressive aphasia: A look at cerebrospinal fluid analytes Progressive aphasias Poster Tuesday 48 T48 PROGRANULIN HAPLOINSUFFICIENCY REDUCES AMYLOID BETA DEPOSITION IN ALZHEIMER S DISEASE MOUSE MODEL Neuropathology Poster Tuesday 49 T49 EFFECTS OF GROUP THERAPY ON PATIENTS WITH SEMANTIC DEMENTIA AND CAREGIVERS Caregiver Poster Tuesday 50 T50 DIFFERENTIATION OF PRIMARY PROGRESSIVE APHASIA VARIANTS Progressive aphasias Poster Tuesday 51 T51 The lived caregiver experience of behavioral variant frontotemporal dementia (bvftd) compared to early-onset Alzheimer s disease (EOAD) caregivers Caregiver Poster Tuesday 52 T52 Mindfulness-Based Stress Reduction in at-risk mutation carriers of familial FTD Treatment (pharmacological / non-pharmacological) Poster Tuesday 53 T53

5 PRIMACY EFFECTS IN WORD LIST LEARNING TESTS DIFFERENTIATE BETWEEN AMNESTIC BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA AND ALZHEIMER S Social cognition and behavior Poster Tuesday 54 T54 DISEASE SafeHome: An app for FTD caregivers Caregiver Poster Tuesday 55 T55 From lab to lounge: Transfer of treatment gains to conversational speech in primary progressive aphasia Progressive aphasias Poster Tuesday 56 T56 TRANSITION TO RESIDENTIAL CARE IN FRONTOTEMPORAL DEMENTIA: A QUALITATIVE STUDY EXAMINING THE EXPERIENCE OF FAMILY CARERS Caregiver Poster Tuesday 57 T57 The Association between Frontotemporal Lobar Degeneration and Bullous Pemphigoid Blood and imaging biomarkers Poster Tuesday 58 T58 Evidence of corticofugal transneuronal tau spreading in humans with frontotemporal dementia Neuropathology Poster Tuesday 59 T59 The long and winding road: journey from first symptom to diagnosis in probable FTD syndromes Caregiver Poster Tuesday 60 T60 When is it not bvftd? Caregiver Poster Tuesday 61 T61 TRACKING SPEECH PRODUCTION CHANGES AND UNDERLYING BRAIN ATROPHY OVER TIME IN NON-SEMANTIC VARIANTS OF PRIMARY PROGRESSIVE APHASIA Progressive aphasias Poster Tuesday 62 T62 MAPPING BEHAVIOURAL AND CORTICAL TRAJECTORIES IN NON-FLUENT PRIMARY PROGRESSIVE APHASIAS AND ALZHEIMER'S DISEASE: A ROLE FOR EMOTION Progressive aphasias Poster Tuesday 63 T63 PROCESSING THE INITIAL CONTACT BETWEEN THE FTD PATIENT AND THE HEALTH CARE SYSTEM: REASONS FOR AND PERSONS BEHIND Neuropathology Poster Tuesday 64 T64 THE LOCUS COERULEUS IN FTLD Neuropathology Poster Tuesday 65 T65 Prognostic Impact of Apathy in Frontotemporal Lobar Degeneration Syndromes Social cognition and behavior Poster Tuesday 66 T66 QUALITY OF LIFE AND CAREGIVER BURDEN IN FAMILIAL FRONTOTEMPORAL DEMENTIA: ANALYSES IN THE LEFFTDS COHORT Caregiver Poster Tuesday 67 T67 Early- versus late-onset non-fluent variant primary progressive aphasia Progressive aphasias Poster Tuesday 68 T68 Amyloid Positive Late-onset Semantic Variant Primary Progressive Aphasia Progressive aphasias Poster Tuesday 69 T69 Understanding the role of TAR-DNA binding protein 43 (TDP43) in oligodendrocyte maturation and the potential link to the disease pathogenesis of Frontotemporal Neuropathology Poster Tuesday 70 T70 Dementia (FTD). A review of mealtime difficulties in the clinical syndromes of frontotemporal lobar degeneration Social cognition and behavior Poster Tuesday 71 T71 Olfactory and gustatory function in frontotemporal lobar degeneration - a review and new tool for assessment Social cognition and behavior Poster Tuesday 72 T72 THE PATHOLOGICAL SUBSTRATE FOR PSYCHOSIS IN FRONTOTEMPORAL DEMENTIA Neuropathology Poster Tuesday 73 T73 ATTENTIONAL LAPSES ON A REACTION TIME TASK PREDICT DEMENTIA SYNDROMES Social cognition and behavior Poster Tuesday 74 T74 Detection of residual cognitive functions using a passive eye-movement paradigm in patients with advanced dementia Caregiver Poster Tuesday 75 T75 NUCLEAR TDP-43 DEPLETION WITH OR WITHOUT TDP-43 AGGREGATION IS ASSOCIATED WITH SOMATODENDRITIC ATROPHY Neuropathology Poster Tuesday 77 T77 SALIENCE AND DEFAULT MODE NETWORK CONNECTIVITY CHANGES IN FRONTOTEMPORAL DEMENTIA SUBTYPES Blood and imaging biomarkers Poster Tuesday 78 T78 Positive behavioural support: an innovative approach for behavioural support in frontotemporal dementia Treatment (pharmacological / non-pharmacological) Poster Tuesday 79 T79 MICROGLIAL SUBTYPES DIFFERENTIALLY RELATE TO NEURONAL DENSITIES AND IN VIVO CORTICAL ATROPHY IN PRIMARY PROGRESSIVE APHASIA CAUSED BY Neuropathology Poster Tuesday 80 T80 ALZHEIMER S DISEASE Exploratory investigation of CSF proteins in familial frontotemporal dementia. Blood and imaging biomarkers Poster Tuesday 81 T81 NEUROINFLAMMATION IS DIFFERENT IN ALS AND FTD AND LINKED TO THE CLINICAL PHASE Blood and imaging biomarkers Poster Tuesday 82 T82 Vulnerability of von Economo neurons and fork cells in the right anterior insula is associated with network-based brain atrophy and empathy deficits in patients with Blood and imaging biomarkers Poster Tuesday 83 T83 frontotemporal dementia DEVELOPMENT OF THE STANDARDISED, MULTILINGUAL MINI LINGUISTIC STATE EXAMINATION (MLSE) TO CLASSIFY AND MONITOR PRIMARY PROGRESSIVE APHASIA Progressive aphasias Poster Tuesday 84 T84 FDG-PET ABNORMALITY PATTERNS IN PRECLINICAL FTD MUTATION CARRIERS Blood and imaging biomarkers Poster Tuesday 85 T85 'Probable' behavioural variant frontotemporal dementia can be caused by Alzheimer's pathology Neuropathology Poster Tuesday 86 T86 PROFILES OF EPISODIC MEMORY IMPAIRMENT IN TYPICAL AND ATYPICAL VARIANTS OF ALZHEIMER S DISEASE Progressive aphasias Poster Tuesday 88 T88 LONGITUDINAL STABILITY OF VOLUMETRICALLY CLASSIFIED BEHAVIORAL-VARIANT FRONTOTEMPORAL DEMENTIA SUBTYPES Blood and imaging biomarkers Poster Tuesday 89 T89 AGE-ASSOCIATED PROTEINS IN CEREBROSPINAL FLUID FROM FRONTOTEMPORAL DEMENTIA PATIENTS AND THEIR RELATIVES Blood and imaging biomarkers Poster Tuesday 90 T90 SPOUSES PERCEPTION OF BEHAVIOURAL SYMPTOMS: A COMPARISON OF BEHAVIOURAL-VARIANT FRONTOTEMPORAL DEMENTIA AND ALZHEIMER S DISEASE Caregiver Poster Tuesday 91 T91 PREDICTION OF BRAIN ATROPHY WITH PLASMA NEUROFILAMENT LIGHT CHAIN IN GENETIC FRONTOTEMPORAL DEMENTIA Blood and imaging biomarkers Poster Tuesday 92 T92 TDCS IMPROVES SYMPTOMS OF PSP Treatment (pharmacological / non-pharmacological) Poster Tuesday 93 T93 tdcs Stimulation improves executive function in People living with Dementia Treatment (pharmacological / non-pharmacological) Poster Tuesday 94 T94 Living Positively with Primary Progressive Aphasia: What do People Say? Progressive aphasias Poster Tuesday 95 T95 ROBUST DATA-DRIVEN COMPUTATIONAL APPROACH FOR CLASSIFYING FRONTOTEMPORAL NEURODEGENERATION: A MULTIMODAL AND MULTI-CENTER NEUROIMAGING STUDY Blood and imaging biomarkers Poster Tuesday 96 T96 EXPLORING THE USE OF EEG BRAIN CONNECTIVITY AS A POTENTIAL BIOMARKER OF FRONTOTEMPORAL DEMENTIA Blood and imaging biomarkers Poster Tuesday 97 T97 MULTICENTRIC VALIDATION OF A NON-LINEAR MEASURE TO ASSESS FMRI RESTING-STATE CONNECTIVITY IN FRONTOTEMPORAL DEMENTIA Blood and imaging biomarkers Poster Tuesday 98 T98 A MACHINE LEARNING APPROACH TO EVALUATE NEUROCOGNITIVE BIOMARKERS RELIABILITY IN NEURODEGENERATIVE DISEASES ACROSS COUNTRIES Blood and imaging biomarkers Poster Tuesday 99 T99

6 Intensive Language Training Combined with Transcranial Stimulation in Patients with Logopenic Aphasia Treatment (pharmacological / non-pharmacological) Poster Tuesday 100 T100 Concrete and abstract concepts processing in semantic variant Progressive Primary Aphasia Progressive aphasias Poster Tuesday 101 T101 PRODROMAL BVFTD SYMPTOMS IN THE C9ORF72 REPEAT EXPANSION CARRIERS AND NON-CARRIERS Social cognition and behavior Poster Tuesday 102 T102 Right or wrong? Reduced emotional response to moral conflict in bvftd is associated with loss of social knowledge Social cognition and behavior Poster Tuesday 103 T103 ASSESSING THE CONTRIBUTIONS OF STRUCTURAL AND FUNCTIONAL CONNECTIVITY TO SEMANTIC ABILITY OF PATIENTS WITH FRONTOTEMPORAL LOBAR Blood and imaging biomarkers Poster Tuesday 104 T104 DEGENERATION Identification of candidate CSF biomarkers by mass spectrometry in genetic frontotemporal dementia. Blood and imaging biomarkers Poster Tuesday 105 T105 SINGLE-WORD COMPREHENSION DEFICITS IN THE NONFLUENT VARIANT OF PRIMARY PROGRESSIVE APHASIA Progressive aphasias Poster Tuesday 106 T106 POSSIBLE CONTRIBUTION OF ALZHEIMER S DISEASE PATHOLOGY TO FRONTOTEMPORAL LOBAR DEGENERATION SYNDROMES. Blood and imaging biomarkers Poster Tuesday 107 T107 SpeechFTLD A multinational consortium for objective assessment and monitoring of speech in Front-temporal lobar degeneration Progressive aphasias Poster Tuesday 108 T108 Differentiating FTD and Primary Progressive Aphasias using speech analysis Progressive aphasias Poster Tuesday 109 T109 BETTER CONVERSATIONS WITH PRIMARY PROGRESSIVE APHASIA (BCPPA): DEFINING AND REFINING A COMMUNICATION TRAINING PROGRAM FOR PEOPLE WITH Treatment (pharmacological / non-pharmacological) Poster Tuesday 110 T110 PPA AND THEIR CONVERSATION PARTNERS. Microglial phenotypes differ according to gene mutation in familial frontotemporal dementia Neuropathology Poster Tuesday 111 T111 Apathy in behavioral variant - Fronto-Temporal Lobar Degeneration Social cognition and behavior Poster Tuesday 112 T112 Frontotemporal dementia (FTD): recognition, referral and diagnosis Social cognition and behavior Poster Tuesday 113 T113 THE PATHWAY FROM SYMPTOM ONSET TO DIAGNOSIS AND ONGOING MANAGEMENT: CARE OF THE PATIENT WITH FRONTOTEMPORAL DEMENTIA IN A Treatment (pharmacological / non-pharmacological) Poster Tuesday 114 T114 MULTIDISCIPLINARY OUTPATIENT CLINIC. Quetiapine for Behavioral Disturbances in Behavioral Variant of Frontotemporal Dementia Treatment (pharmacological / non-pharmacological) Poster Tuesday 115 T115 Serotonergic Agents Improved Behavioral Disinhibition in Behavioral Variant of Frontotemporal Dementia Treatment (pharmacological / non-pharmacological) Poster Tuesday 116 T116 LYSOSOMAL CHANGES CHARACTERIZING FRONTOTEMPORAL DEMENTIA Neuropathology Poster and Data Blitz Wednesday 1 W1 TDP-43 Enrichment Using High Affinity RNA Aptamers Blood and imaging biomarkers Poster and Data Blitz Wednesday 2 W2 CYTOPLASMIC TDP-43 ALTERS SOLUBILITY, ABUNDANCE AND LOCALISATION OF NUMEROUS PROTEINS IN NEURONS WITH FTD PATHOLOGY Neuropathology Poster and Data Blitz Wednesday 3 W3 PROGRANULIN MEDIATES ENDOLYSOSOMAL RECRUITMENT OF THE RNP-ASSOCIATED PROTEIN ANXA11 Mechanisms of cell death Poster and Data Blitz Wednesday 4 W4 COMPARISON OF AUTOMATED BRAIN SEGMENTATION TOOLS IN FTD: IMPLICATIONS FOR IMAGING BIOMARKER CHOICE IN CLINICAL TRIALS Blood and imaging biomarkers Poster and Data Blitz Wednesday 6 W6 CSF Biomarkers Predict Trajectory in Frontotemporal Dementia Variants Blood and imaging biomarkers Poster and Data Blitz Wednesday 7 W7 GENFI-COG: DEVELOPING A COGNITIVE COMPOSITE SCORE FOR PRESYMPTOMATIC GENETIC FTD THERAPEUTIC TRIALS Treatment (pharmacological / non-pharmacological) Poster and Data Blitz Wednesday 8 W8 A Phase 1b Open Labelled Study of Sodium Selenate as a Disease Modifying Treatment for Possible Behavioural Variant Fronto-temporal Dementia Treatment (pharmacological / non-pharmacological) Poster and Data Blitz Wednesday 9 W9 CSF NFL, TAU AND Aβ42 AS MEASURES OF DISEASE SEVERITY AND PREDICTORS OF COGNITIVE DECLINE IN YOUNG-ONSET DEMENTIA Blood and imaging biomarkers Poster and Data Blitz Wednesday 10 W10 Distinct RNA metabolism in FTLD and ALS phenotypes in frontal and occipital cortices Genetics Poster and Data Blitz Wednesday 11 W11 THE SPECTRUM OF LANGAUGE IMPAIRMENTS IN AMYTROPHIC LATERAL SCLEROSIS CBS, PSP, MND Poster and Data Blitz Wednesday 12 W12 Language impairments in FTD-MND CBS, PSP, MND Poster and Data Blitz Wednesday 13 W13 NEUROPATHOLOGY AND PATHOGENESIS OF EARLY ONSET AMYOTROPHIC LATERAL SCLEROSIS ASSOCIATED WITH A TARDBP S375G VARIANT CBS, PSP, MND Poster and Data Blitz Wednesday 14 W14 THE THALAMUS IS A PATHOLOGICAL MICROCOSM IN THE FTD-ALS SPECTRUM CBS, PSP, MND Poster Wednesday 15 W15 Neuropsychiatric phenotype during the life course of bvftd patients with the C9orf72 mutation Genetics Poster and Data Blitz Wednesday 16 W16 WHAT IS APATHY IN FRONTOTEMPORAL DEMENTIAS? Social cognition and behavior Poster and Data Blitz Wednesday 17 W17 CONTRIBUTION OF WHITE MATTER HYPERINTENSITIES ON T2-WEIGHTED IMAGES TO NEUROPSYCHIATRIC MANIFESTATIONS OF ALZHEIMER S DISEASE AND Blood and imaging biomarkers Poster and Data Blitz Wednesday 18 W18 FRONTOTEMPORAL LOBAR DEGENERATION DISEASE TRAJECTORIES IN BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA, PRIMARY PSYCHIATRIC AND OTHER NEURODEGENERATIVE DISORDERS Social cognition and behavior Poster and Data Blitz Wednesday 19 W19 PRESENTING WITH BEHAVIOURAL CHANGE Multidimensional apathy profiles in frontotemporal dementia and Alzheimer s disease: Considering the role of disease course Social cognition and behavior Poster and Data Blitz Wednesday 20 W20 DISTINCT FACIAL SCANNING PATTERNS IN RIGHT- AND LEFT-LATERALIZED SEMANTIC DEMENTIA Social cognition and behavior Poster and Data Blitz Wednesday 21 W21 PRESYMPTOMATIC IMPAIRMENT OF SOCIAL BEHAVIOUR IN MAPT MUTATION CARRIERS WITHIN THE GENFI COHORT Social cognition and behavior Poster and Data Blitz Wednesday 22 W22 A META-ANALYSIS OF NEUROPSYCHOLOGICAL, SOCIAL COGNITIVE, AND OLFACTORY MEASUREMENTS FOR THE BEHAVIORAL AND LANGUAGE VARIANTS OF Social cognition and behavior Poster and Data Blitz Wednesday 23 W23 FRONTOTEMPORAL DEMENTIA Social interactions in frontotemporal dementia and Alzheimer s disease: a systematic video analysis of non-scripted conversations. Social cognition and behavior Poster and Data Blitz Wednesday 24 W24 IMPAIRED MENTAL SIMULATION IN THE BEHAVIOURAL VARIANT OF FRONTOTEMPORAL DEMENTIA: A NOVEL COGNITIVE MECHANISM UNDERLYING SOCIAL DYSFUNCTION? Social cognition and behavior Poster and Data Blitz Wednesday 25 W25 Predicting Corticobasal Syndrome and Alien/ Anarchic Limb Syndrome from Magnetic Resonance Imaging CBS, PSP, MND Poster Wednesday 26 W26 FRONTAL AND TEMPORAL RHYTMIC DELTA ACTIVITIES IN A FRONTOTEMPORAL DEMENTIA PATIENT Blood and imaging biomarkers Poster Wednesday 27 W27 IDENTIFICATION OF FACIAL EMOTIONS IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE IMPAIRMENT AND MILD COGNITIVE IMPAIRMENT Social cognition and behavior Poster Wednesday 28 W28 MULTIMODAL MRI BIOMARKERS SUPPORT INDIVIDUAL DIAGNOSIS OF CORTICOBASAL SYNDROME CBS, PSP, MND Poster Wednesday 29 W29

7 ASSOCIATION OF PERFORMANCE ON EXECUTIVE FUNCTION TASKS WITH THEORY OF THE MIND EVALUATIONS IN PATIENTS WITH ALZHEIMER'S DISEASE, MILD Social cognition and behavior Poster Wednesday 30 W30 COGNITIVE IMPAIRMENT AND HEALTHY SUBJECTS Protein profiles in cerebrospinal fluid and plasma associated to frontotemporal dementia Blood and imaging biomarkers Poster Wednesday 31 W31 Memory complain and performance at first clinical presentation among FTLD pathologies Social cognition and behavior Poster Wednesday 32 W32 [18F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansion Blood and imaging biomarkers Poster Wednesday 33 W33 Evidence for early neuroinflammation in a healthy MAPT mutation carrier Blood and imaging biomarkers Poster Wednesday 34 W34 Comparison of lipidomic analysis of Frontotemporal dementia and Alzheimer's disease brain Disease modulation Poster Wednesday 35 W35 THE CEREBELLUM IN FRONTOTEMPORAL DEMENTIA: A META-ANALYSIS OF NEUROIMAGING STUDIES Blood and imaging biomarkers Poster Wednesday 36 W36 LONGITUDINAL CEREBELLAR GREY MATTER CHANGES AND THEIR RELATIONS WITH COGNITIVE PROGRESSION IN FRONTOTEMPORAL DEMENTIAS Social cognition and behavior Poster Wednesday 37 W37 SENSITIVITY OF CLINICAL CRITERIA FOR POSSIBLE CORTICOBASAL DEGENERATION CBS, PSP, MND Poster Wednesday 38 W38 DIFFERENCE IN THE CLINICAL CHARACTERISTICS OF CORTICOBASAL SYNDROME PATIENTS WITH PATHOLOGICALLY CONFIRMED CORTICOBASAL DEGENERATION CBS, PSP, MND Poster Wednesday 39 W39 VERSUS THOSE WITHOUT CSF SYNAPTIC PROTEIN CONCENTRATIONS ARE RAISED IN THOSE WITH ALZHEIMER'S DISEASE PATHOLOGY BUT NOT IN THOSE WITH FRONTOTEMPORAL DEMENTIA Blood and imaging biomarkers Poster Wednesday 40 W40 A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia - Background and Progress Report Treatment (pharmacological / non-pharmacological) Poster Wednesday 41 W41 PRESYMPTOMATIC ABNORMAL PERCEPTION OF PAIN IN C9ORF72 EXPANSIONS CARRIERS: EARLY AUTONOMIC CHANGES IN THE GENFI COHORT. Social cognition and behavior Poster Wednesday 42 W42 Focal neurodegeneration increases local and network-level connectivity during complex cognition Blood and imaging biomarkers Poster Wednesday 43 W43 Altered neuronal lysosomal functioning in the anterior cingulate cortex in frontotemporal dementia Mechanisms of cell death Poster Wednesday 44 W44 WHEN COMPUTER MODELING MEETS EXPERIMENTS. STUDYING THE ELECTROPHYSIOLOGICAL CONSEQUENCES OF THE FTD V337M TAU MUTATION Disease modulation Poster Wednesday 45 W45 Examining the cognitive phenotype of behavioural variant frontotemporal dementia using a tablet based assessment tool Social cognition and behavior Poster Wednesday 46 W46 Distinct patterns of longitudinal cortical thinning and perfusion in behavioral variant frontotemporal degeneration Blood and imaging biomarkers Poster Wednesday 48 W48 18F-flortaucipir uptake in corticobasal syndrome CBS, PSP, MND Poster Wednesday 49 W49 Indirect speech act comprehension in behavioral variant frontotemporal degeneration and mild cognitive impairment Social cognition and behavior Poster Wednesday 50 W50 An autopsy case report of PSP complicated with chronic schizophrenia CBS, PSP, MND Poster Wednesday 51 W51 Investigations of DNAJ protein mediated suppression of Tau aggregation and Tau induced cell death Mechanisms of cell death Poster Wednesday 52 W52 The Utility of the Mild Behavioral Impairment-Checklist in Detecting Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Social cognition and behavior Poster Wednesday 53 W53 POTENTIAL SYNAPTIC DYSFUNCTION IN C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSION-ASSOCIATED FRONTOTEMPORAL DEMENTIA Mechanisms of cell death Poster Wednesday 54 W54 MENTAL RIGIDITY IN THE BEHAVIOURAL VARIANT OF FRONTOTEMPORAL DEMENTIA NEURAL CORRELATES AND CLINICAL IMPLICATIONS Social cognition and behavior Poster Wednesday 55 W55 A CASE OF NON-AMNESTIC COGNITIVE IMPAIRMENT WITH A CEREBROSPINAL FLUID BIOMARKER PROFILE OF ALZHEIMER DISEASE AS PRODROMAL PRESENTATION CBS, PSP, MND Poster Wednesday 56 W56 OF A CONCOMITANT AMYOTROPHIC LATERAL SCLEROSIS AND CEREBRAL AMYLOID ANGIOPATHY MODELING OF LYSOSOME DYSFUNCTION DUE TO PROGRANULIN DEFICIENCY Treatment (pharmacological / non-pharmacological) Poster Wednesday 57 W57 A degradation pathway for the FTLD causing C9orf72 repeat RNA Disease modulation Poster Wednesday 58 W58 Lipid and lipoprotein analyses of behavioural variant frontotemporal dementia Blood and imaging biomarkers Poster Wednesday 59 W59 Phloroglucinol ameliorates the cognitive impairments in 5XFAD mice by reducing amyloid β peptide burden and proinflammatory cytokines in the hippocampus Disease modulation Poster Wednesday 60 W60 Role of semantic memory in the recognition of emotions conveyed by words and music Social cognition and behavior Poster Wednesday 61 W61 The Dépistage Cognitif de Québec (DCQ): A New Clinician's Tool for Early Recognition of Atypical Dementia Social cognition and behavior Poster Wednesday 62 W62 Distinct neuroanatomical correlates of neuropsychiatric symptoms in the three main forms of genetic frontotemporal dementia in the GENFI cohort Social cognition and behavior Poster Wednesday 63 W63 Presymptomatic MAPT mutation carriers show gray and white matter deficits similar to atrophy patterns during the symptomatic phase Blood and imaging biomarkers Poster Wednesday 64 W64 Gyrification abnormalities in presymptomatic C9ORF72 expansion carriers Blood and imaging biomarkers Poster Wednesday 65 W65 C9orf72 in proteasome- and autophagy-mediated protein degradation pathways Mechanisms of cell death Poster Wednesday 66 W66 SOCIAL COGNITION AND EXECUTIVE FUNCTION IN THE AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA CONTINUUM. Social cognition and behavior Poster Wednesday 67 W67 Hippocampal shape analysis in frontotemporal dementia and Alzheimer s disease Blood and imaging biomarkers Poster Wednesday 68 W68 Affibody-mediated sequestration of aggregation-prone proteins for prevention of neurodegenerative disorders Treatment (pharmacological / non-pharmacological) Poster Wednesday 69 W69 IDENTIFICATION OF NEW HDAC INHIBITORS FOR THE TREATMENT OF FTD-GRN Treatment (pharmacological / non-pharmacological) Poster Wednesday 70 W70 LONGITUDINAL 18F-AV-1451 BINDING IN FAMILIAL FRONTOTEMPORAL LOBAR DEGENERATION WITH TAU PATHOLOGY Blood and imaging biomarkers Poster Wednesday 71 W71 COGNITIVE INDICATORS OF PRECLINICAL BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA IN MAPT CARRIERS Social cognition and behavior Poster Wednesday 72 W72 Genetic predictors of survival in frontotemporal degeneration Genetics Poster Wednesday 74 W74 Development of secondary phenotypes within the ALS/FTD spectrum in the presence of C9orf72 expansions Genetics Poster Wednesday 75 W75 Intermediate-length ataxin-2 polyglutamine repeats are associated with disease phenotype in ALS CBS, PSP, MND Poster Wednesday 76 W76 Accounting for motion during MRI improves sensitivity for detecting anatomic differences between FTD and ALS Blood and imaging biomarkers Poster Wednesday 78 W78 IMPACT OF ALZHEIMERS DISEASE CO-PATHOLOGY ON AMYOTROPHIC LATERAL SCLEROSIS WITH AND WITHOUT FRONTOTEMPORAL DEGENERATION CBS, PSP, MND Poster Wednesday 79 W79 ABSENCE OF EMBARRASSABILITY DISTINGUISHES FRONTOTEMPORAL DEMENTIA FROM ALZHEIMER S DISEASE AND HEALTHY CONTROLS Social cognition and behavior Poster Wednesday 80 W80 NEUROPSYCHIATRIC SYMPTOMS AND THE ULTIMATUM GAME IN FRONTOTEMPORAL DEMENTIA COMPARED TO ALZHEIMER S DISEASE Social cognition and behavior Poster Wednesday 81 W81

8 EMOTIONAL EMPATHY IN FRONTOTEMPORAL DEMENTIA COMPARED TO ALZHEIMER S DISEASE AND HEALTHY CONTROLS Social cognition and behavior Poster Wednesday 82 W82 THE CONTRIBUTION OF HEMISPHERIC ASYMMETRY TO SOCIOEMOTIONAL BEHAVIOR IN FRONTOTEMPORAL DEMENTIA Social cognition and behavior Poster Wednesday 83 W83 THE RELATIONSHIP OF MANIC-LIKE BEHAVIOR WITH FRONTOTEMPORAL DEMENTIA Social cognition and behavior Poster Wednesday 84 W84 REGIONALLY SPECIFIC VARIATION IN BRAIN STRUCTURE IN BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA COMPARED TO ALZHEIMER S DEMENTIA Blood and imaging biomarkers Poster Wednesday 85 W85 IMMUNOLOGICAL SIGNATURES DISTINGUISH FTLD-TDP FROM FTLD-TAU DISORDERS ACROSS CLINICALLY DEFINED, GENETIC, AND PATHOLOGICALLY PROVEN Blood and imaging biomarkers Poster Wednesday 86 W86 COHORTS. SERIAL 18F-AV-1451 TAU-PET IN MAPT MUTATION CARRIERS Blood and imaging biomarkers Poster Wednesday 87 W87 UTILITY OF THE FTLD-CDR COMPARED TO THE STANDARD CDR IN THE MILD FTLD SPECTRUM: DATA FROM THE ARTFL/LEFFTDS CONSORTIUM Social cognition and behavior Poster Wednesday 88 W88 Cognitive inhibition impairments and gray matter atrophy in pre-symptomatic C9orf72 mutation carriers Social cognition and behavior Poster Wednesday 89 W89 MUSCLE PROFILE AND PROGRESSION OF DEMENTA Disease modulation Poster Wednesday 90 W90 ENDOGENOUS AND EXOGENOUS MODULATIONS OF DPR EXPRESSION FROM C9ORF72 REPEAT EXPANSION Disease modulation Poster Wednesday 91 W91 EXAMINING ASSOCIATION BETWEEN SOCIAL COGNITION AND RESTING STATE CONNECTIVITY IN FRONTOTEMPORAL DEMENTIA, ALZHEIMER S DISEASE, Social cognition and behavior Poster Wednesday 92 W92 PARKINSON S DISEASE AND HEALTHY CONTROLS Affinity proteomics for array-based profiling of proteins and autoantibody repertoires in CSF and plasma Blood and imaging biomarkers Poster Wednesday 93 W93 ABNORMAL FEEDING IS ASSOCIATED WITH OFC AND INSULA CORTICAL THICKNESS IN FRONTOTEMPORAL DEMENTIA Disease modulation Poster Wednesday 94 W94 The Generation of Novel Ideas in Behavioural Variant Frontotemporal Dementia Social cognition and behavior Poster Wednesday 97 W97 LANGUAGE IMPAIRMENT IN PROGRESSIVE SUPRANUCLEAR PALSY AND CORTICOBASAL SYNDROME CBS, PSP, MND Poster Wednesday 98 W98 Right temporal variant of FTD revisited: a unique clinical syndrome? Social cognition and behavior Poster Wednesday 99 W99 EXTENDING THE PHENOTYPE OF CORTICOBASAL SYNDROME: DISTINCT AMNESIC PROFILES AND NEURAL CORRELATES CBS, PSP, MND Poster Wednesday 100 W100 ALTERED TIME AWARENESS IN FRONTOTEMPORAL DEMENTIA SYNDROMES AND ALZHEIMER S DISEASE Social cognition and behavior Poster Wednesday 101 W101 In genetic frontotemporal dementia, functional network efficiency is maintained until the onset of symptoms: evidence for functional resilience to structural change. Blood and imaging biomarkers Poster Wednesday 102 W102 CHARACTERISING VERBAL ADYNAMIA IN PARKINSONIAN DISORDERS CBS, PSP, MND Poster Wednesday 103 W103 Gut-brain axis in dementia assessed by microbiome analyses in humans and mouse models Disease modulation Poster Wednesday 104 W104 EFFECTS OF THE C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSION ON CULTURED NEURONAL AND MICROGLIAL CELLS Mechanisms of cell death Poster Wednesday 105 W105 Ultrasensitive detection and discrimination of tau seeding activities associated with Alzheimer disease, progressive supranuclear palsy, and other diseases with tau CBS, PSP, MND Poster Wednesday 106 W106 pathology DISTINCT AGE-RELATED CORTICAL THINNING IN ASYMPTOMATIC PROGRANULIN (GRN) MUTATION CARRIERS Blood and imaging biomarkers Poster Wednesday 107 W107 SLEEP PHENOTYPES OF FRONTOTEMPORAL DEMENTIA Social cognition and behavior Poster Wednesday 108 W108 Resting parasympathetic dysfunction predicts prosocial helping deficits in behavioral variant frontotemporal dementia Social cognition and behavior Poster Wednesday 109 W109 Ventricular Volume Expansion in Pre-symptomatic Genetic Frontotemporal Dementia Blood and imaging biomarkers Poster Wednesday 110 W110 fmri during Reversal Learning in Frontotemporal Dementia Social cognition and behavior Poster Wednesday 111 W111 DISEASE MODEL FOR GRN-LINKED FTLD USING PATIENT- AND ENGINEERED STEM CELLS. Mechanisms of cell death Poster Wednesday 112 W112 18F-flortaucipir tau PET in frontotemporal dementia syndromes Blood and imaging biomarkers Poster Wednesday 113 W113 Presymptomatic abnormalities in segmented size and shape of the brain in monogenic FTLD Blood and imaging biomarkers Poster Wednesday 114 W114 Longitudinal [18F]AV-1451 PET imaging in Progressive Supranuclear Palsy (PSP) CBS, PSP, MND Poster Wednesday 115 W115 Mechanisms of psychosis and psychosis-risk in motor neurone disease and frontotemporal dementia with motor neurone disease CBS, PSP, MND Poster and Data Blitz Wednesday 116 W116 The special price of zero: an affective evaluation based on ventromedial prefrontal cortex integrity Social cognition and behavior Poster Wednesday 117 W117 NEREUGULIN1 REGULATES AMYLOID PRECURSOR PROTEIN CELL SURFACE EXPRESSION AND NON-AMYLOIDOGENIC PROCESSING Mechanisms of cell death Poster Wednesday 118 W118 11C-ER176 HAS SUPERIOR QUALITY THAN 11C-PBR28 TO IMAGE BRAIN INFLAMMATION WITH POSITRON EMISSION TOMOGRAPHY Blood and imaging biomarkers Poster Wednesday 119 W119 Plasma oxytocin has limited associations with social behaviour in frontotemporal dementia syndromes Social cognition and behavior Poster Wednesday 120 W120 MULTI-MODEL COGNITIVE TRAINING FOR MILD COGNITIVE IMPAIRMENT PATIENTS: CLINICAL AND FUNCTIONAL NEUROIMAGING OUTCOMES FROM A PILOT STUDY Treatment (pharmacological / non-pharmacological) Poster Wednesday 121 W121 Gene Mutation Screening for Chinese Patients with Frontotemporal Dementia Genetics Poster Wednesday 122 W122 Advancing Clinical and Biomarker Research in AD: The LEAD Study Blood and imaging biomarkers Poster Wednesday 123 W123 SOCIAL COGNITION DEFICITS ARE COMMON IN BOTH MOTOR AND LANGUAGE VARIANTS OF FRONTOTEMPORAL DEMENTIA Social cognition and behavior Poster Wednesday 125 W125

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer MRC Clinician Scientist Honorary Consultant Neurologist Dementia Research Centre, UCL Institute of Neurology

More information

Form D1: Clinician Diagnosis

Form D1: Clinician Diagnosis Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.

More information

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Dementia Update Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Nothing to disclose Dementia Progressive deterioration in mental function

More information

! slow, progressive, permanent loss of neurologic function.

! slow, progressive, permanent loss of neurologic function. UBC ! slow, progressive, permanent loss of neurologic function.! cause unknown.! sporadic, familial or inherited.! degeneration of specific brain region! clinical syndrome.! pathology: abnormal accumulation

More information

LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION

LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION Murray Grossman University of Pennsylvania Support from NIH (AG17586, AG15116, NS44266, NS35867, AG32953, AG38490), IARPA, ALS Association, and the

More information

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS Norman L. Foster, M.D. Director, Center for Alzheimer s Care, Imaging and Research Chief, Division of Cognitive Neurology, Department of Neurology

More information

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia Bradley F. Boeve, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Alzheimer s Disease

More information

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD OBJECTIVES Terminology/Dementia Basics Most Common Types Defining features Neuro-anatomical/pathological underpinnings Neuro-cognitive

More information

FTD basics! Etienne de Villers-Sidani, MD!

FTD basics! Etienne de Villers-Sidani, MD! FTD basics! Etienne de Villers-Sidani, MD! Frontotemporal lobar degeneration (FTLD) comprises 3 clinical syndromes! Frontotemporal dementia (behavioral variant FTD)! Semantic dementia (temporal variant

More information

I do not have any disclosures

I do not have any disclosures Alzheimer s Disease: Update on Research, Treatment & Care Clinicopathological Classifications of FTD and Related Disorders Keith A. Josephs, MST, MD, MS Associate Professor & Consultant of Neurology Mayo

More information

Biomarkers: Translating Research into Clinical Practice

Biomarkers: Translating Research into Clinical Practice Biomarkers: Translating Research into Clinical Practice AFTD Education Conference San Diego, April 2015 Nadine Tatton, PhD Scientific Director, AFTD HelpLine 866-5507-7222 u info@theaftd.org u www.theaftd.org

More information

Clinical Genetics & Dementia

Clinical Genetics & Dementia Clinical Genetics & Dementia Dr Nayana Lahiri Consultant in Clinical Genetics & Honorary Senior Lecturer Nayana.lahiri@nhs.net Aims of the Session To appreciate the potential utility of family history

More information

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1 Frontotemporal Degeneration and Primary Progressive Aphasia Caregiver and Professional Education Conference Diana R. Kerwin, MD Assistant Professor of Medicine-Geriatrics Cognitive Neurology and Alzheimer

More information

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Dementia Update October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Outline New concepts in Alzheimer disease Biomarkers and in vivo diagnosis Future trends

More information

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration Annual Scientific Meeting Canadian Geriatric Society Philippe Desmarais,

More information

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce ALESSANDRO MARTORANA UOC NEUROLOGIA-CENTRO ALZHEIMER POLICLINICO TOR VERGATA-UNIVERSITÀ DI ROMA TOR VERGATA

More information

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion Alzheimer s and Dementia Research: An Advanced Discussion Brad Boeve, MD Department of Neurology Mayo Clinic Alzheimer s and Dementia Research: An Advanced Discussion Theoretical Constructs in Aging/Dementia

More information

Frontotemporal dementia:

Frontotemporal dementia: Frontotemporal dementia: Where we ve been What s on the horizon Howard Rosen, M.D. UCSF Department of Neurology Memory and Aging Center www.memory.ucsf.edu None Disclosures Overview FTD, What is it? Origins

More information

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney. I.1 I.2 II.1 II.2 II.3 II.4 II.5 II.6 III.1 III.2 III.3 III.4 III.5 III.6 III.7 III.8 III.9 III.10 III.11 III.12 IV.1 IV.2 IV.3 IV.4 IV.5 Frontotemporal Dementia: Towards better diagnosis Frontotemporal

More information

Regulatory Challenges across Dementia Subtypes European View

Regulatory Challenges across Dementia Subtypes European View Regulatory Challenges across Dementia Subtypes European View Population definition including Early disease at risk Endpoints in POC studies Endpoints in pivotal trials 1 Disclaimer No CoI The opinions

More information

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal

More information

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit Objectives RAIN Difficult Diagnosis 2014: A 75 year old woman with falls Alexandra Nelson MD, PhD UCSF Memory and Aging Center/Gladstone Institute of Neurological Disease Recognize important clinical features

More information

Emerging CSF and serum biomarkers in atypical dementia. Laksanun Cheewakriengkrai, MD. Phramongkutklao Hospital March 7 th, 2018

Emerging CSF and serum biomarkers in atypical dementia. Laksanun Cheewakriengkrai, MD. Phramongkutklao Hospital March 7 th, 2018 Emerging CSF and serum biomarkers in atypical dementia Laksanun Cheewakriengkrai, MD. Phramongkutklao Hospital March 7 th, 2018 Biomarkers A characteristic that is objectively measured and evaluated as

More information

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009 Sandra Weintraub, Ph.D. Clinical Core Director, Cognitive Neurology and Alzheimer s Disease Center Northwestern University Feinberg School of Medicine Chicago, Illinois Dementia: a condition caused by

More information

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer

More information

Form A3: Subject Family History

Form A3: Subject Family History Initial Visit Packet NACC Uniform Data Set (UDS) Form A: Subject Family History ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by a clinician

More information

Sandra Weintraub, PhD Clinical Core Leader and Professor

Sandra Weintraub, PhD Clinical Core Leader and Professor Sandra Weintraub, PhD Clinical Core Leader and Professor Northwestern Cognitive Neurology and Alzheimer s Disease Center (CNADC) Chicago, Illinois www.brain.northwestern.edu Why is it so difficult to diagnose

More information

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14.

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14. NIH Public Access Author Manuscript Published in final edited form as: Semin Neurol. 2013 September ; 33(4): 386 416. doi:10.1055/s-0033-1359312. Neuroimaging Biomarkers of Neurodegenerative Diseases and

More information

Confronting the Clinical Challenges of Frontotemporal Dementia

Confronting the Clinical Challenges of Frontotemporal Dementia Confronting the Clinical Challenges of Frontotemporal Dementia A look at FTD s symptoms, pathophysiology, subtypes, as well as the latest from imaging studies. By Zac Haughn, Senior Associate Editor Ask

More information

Moving Targets: An Update on Diagnosing Dementia in the Clinic

Moving Targets: An Update on Diagnosing Dementia in the Clinic Moving Targets: An Update on Diagnosing Dementia in the Clinic Eric McDade DO Department of Neurology School of Medicine Alzheimer Disease Research Center Disclosures No relevant financial disclosures

More information

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16 The impact of FDG PET in degenerative dementia diagnosis Jung Lung, Hsu MD, Ph.D (Utrecht) Section of dementia and cognitive impairment Department of Neurology Chang Gung Memorial Hospital, Linkou, Taipei

More information

Non Alzheimer Dementias

Non Alzheimer Dementias Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,

More information

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease

More information

Subject Index. Band of Giacomini 22 Benton Visual Retention Test 66 68

Subject Index. Band of Giacomini 22 Benton Visual Retention Test 66 68 Subject Index Adams, R.D. 4 Addenbrooke s Cognitive Examination 101 Alzheimer s disease clinical assessment histological imaging 104 neuroimaging 101 104 neuropsychological assessment 101 clinical presentation

More information

Mild Cognitive Impairment (MCI)

Mild Cognitive Impairment (MCI) October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine

More information

Neuro degenerative PET image from FDG, amyloid to Tau

Neuro degenerative PET image from FDG, amyloid to Tau Neuro degenerative PET image from FDG, amyloid to Tau Kun Ju Lin ( ) MD, Ph.D Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital ( ) Department of Medical Imaging

More information

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California The National Cell Repository for Alzheimer s Disease (NCRAD) is a data and specimen collection source for families with Alzheimer disease (AD) or serious memory loss. Families having two or more living

More information

Diagnosis and Treatment of Alzhiemer s Disease

Diagnosis and Treatment of Alzhiemer s Disease Diagnosis and Treatment of Alzhiemer s Disease Roy Yaari, MD, MAS Director, Memory Disorders Clinic, Banner Alzheimer s Institute 602-839-6900 Outline Introduction Alzheimer s disease (AD)Guidelines -revised

More information

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language

More information

Update on functional brain imaging in Movement Disorders

Update on functional brain imaging in Movement Disorders Update on functional brain imaging in Movement Disorders Mario Masellis, MSc, MD, FRCPC, PhD Assistant Professor & Clinician-Scientist Sunnybrook Health Sciences Centre University of Toronto 53 rd CNSF

More information

Lecture 42: Final Review. Martin Wessendorf, Ph.D.

Lecture 42: Final Review. Martin Wessendorf, Ph.D. Lecture 42: Final Review Martin Wessendorf, Ph.D. Lecture 33 cortex Heilbronner 5 lobes of the cortex Lateral view (left side) Mid-saggital view (right side) Cellular organization of cortex White matter

More information

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Pathogenesis of Degenerative Diseases and Dementias D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Dementias Defined: as the development of memory impairment and other cognitive deficits

More information

SUPPLEMENTARY MATERIAL. Table. Neuroimaging studies on the premonitory urge and sensory function in patients with Tourette syndrome.

SUPPLEMENTARY MATERIAL. Table. Neuroimaging studies on the premonitory urge and sensory function in patients with Tourette syndrome. SUPPLEMENTARY MATERIAL Table. Neuroimaging studies on the premonitory urge and sensory function in patients with Tourette syndrome. Authors Year Patients Male gender (%) Mean age (range) Adults/ Children

More information

Dementia and Healthy Ageing : is the pathology any different?

Dementia and Healthy Ageing : is the pathology any different? Dementia and Healthy Ageing : is the pathology any different? Professor David Mann, Professor of Neuropathology, University of Manchester, Hope Hospital, Salford DEMENTIA Loss of connectivity within association

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Devenney E, Bartley L, Hoon C, et al. Progression in behavioral variant frontotemporal dementia: a longitudinal study. JAMA Neurol. Published online October 26, 2015. doi:10.1001/jamaneurol.2015.2061.

More information

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019 KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 26, 2019

More information

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019 KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 26, 2019

More information

TUESDAY, MARCH 28, 2017 WEDNESDAY, MARCH 29, 2017 WELCOME RECEPTION (VIENNA CITY HALL)

TUESDAY, MARCH 28, 2017 WEDNESDAY, MARCH 29, 2017 WELCOME RECEPTION (VIENNA CITY HALL) KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 28, 2017

More information

European Prevention of Alzheimer s Dementia (EPAD)

European Prevention of Alzheimer s Dementia (EPAD) European Prevention of Alzheimer s Dementia (EPAD) Ron Marcus, MD ISCTM Adaptive Design Workshop February 20, 2018 1 EPAD Goal The European Prevention of Alzheimer's Dementia (EPAD) project aims to develop

More information

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia Dementia: broad term for any acquired brain condition impairing mental function such that ADLs are impaired. Includes:

More information

Dr Fiona Kumfor University of Sydney

Dr Fiona Kumfor University of Sydney Social Cognition in Dementia: Informing Diagnosis, Prognosis and Management Dr Fiona Kumfor University of Sydney CHANGES IN DEMENTIA Memory Social cognition Language ELEMENTS OF SOCIAL COGNITION Face processing

More information

Re: Request for Information: Updating the Alzheimer s Disease-Related Dementias Research Priorities

Re: Request for Information: Updating the Alzheimer s Disease-Related Dementias Research Priorities Public Policy Division 202.393.7737 p 1212 New York Ave NW 866.865.0270 f Suite 800 www.alz.org Washington, DC 20005 Roderick Corriveau, Ph.D. Program Director National Institute of Neurological Disorders

More information

review of existing studies on ASL in dementia Marion Smits, MD PhD

review of existing studies on ASL in dementia Marion Smits, MD PhD review of existing studies on ASL in dementia Marion Smits, MD PhD Associate Professor of Neuroradiology Department of Radiology, Erasmus MC, Rotterdam (NL) Alzheimer Centre South-West Netherlands, Rotterdam

More information

What is. frontotemporal. address? dementia?

What is. frontotemporal. address? dementia? What is frontotemporal address? dementia? Contents 03 What is frontotemporal dementia? 04 Symptoms 05 Diagnosis 06 Treatments Information in this booklet is for anyone who wants to know more about frontotemporal

More information

Dementia Past, Present and Future

Dementia Past, Present and Future Dementia Past, Present and Future Morris Freedman MD, FRCPC Division of Neurology Baycrest and University of Toronto Rotman Research Institute, Baycrest CNSF 2015 Objectives By the end of this presentation,

More information

PROJECT TRICALS AN INTERNATIONAL COLLABORATION TO FIND EFFECTIVE TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS

PROJECT TRICALS AN INTERNATIONAL COLLABORATION TO FIND EFFECTIVE TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS PROJECT TRICALS AN INTERNATIONAL COLLABORATION TO FIND EFFECTIVE TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS BACKGROUND Amyotrophic Lateral Sclerosis (ALS), also known as Motor Neurone Disease (MND) is

More information

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril Neurodegenerative disorders to be discussed Alzheimer s disease Lewy body diseases Frontotemporal dementia and other tauopathies Huntington s disease Motor Neuron Disease 2 Neuropathology of neurodegeneration

More information

5th Mini-Symposium on Cognition, Decision-making and Social Function: In Memory of Kang Cheng

5th Mini-Symposium on Cognition, Decision-making and Social Function: In Memory of Kang Cheng 5th Mini-Symposium on Cognition, Decision-making and Social Function: In Memory of Kang Cheng 13:30-13:35 Opening 13:30 17:30 13:35-14:00 Metacognition in Value-based Decision-making Dr. Xiaohong Wan (Beijing

More information

Assessing and Managing the Patient with Cognitive Decline

Assessing and Managing the Patient with Cognitive Decline Assessing and Managing the Patient with Cognitive Decline Center of Excellence For Alzheimer s Disease for State of NY Capital Region Alzheimer s Center of Albany Medical Center Earl A. Zimmerman, MD Professor

More information

Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia

Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia 386 Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia Shannon L. Risacher, PhD 1 Andrew J. Saykin, PsyD 1 1 Center for Neuroimaging, Department of Radiology and Imaging Sciences, and Indiana

More information

Theme Topics Subtopics. Basic and Translational Science. Development of New Models and Analysis Methods

Theme Topics Subtopics. Basic and Translational Science. Development of New Models and Analysis Methods Basic and Translational Science Development of New Models and Analysis Methods α-synuclein Amyloid/Abeta Behavioral models Inflammation Novel assays and technologies Screening studies/platforms Seeding

More information

FDG-PET e parkinsonismi

FDG-PET e parkinsonismi Parkinsonismi FDG-PET e parkinsonismi Valentina Berti Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Sez. Medicina Nucleare Università degli Studi di Firenze History 140 PubMed: FDG AND parkinsonism

More information

Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues

Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic s? The Debate Continues Ever since new criteria came out for a research diagnosis of prodromal/preclinical

More information

Imaging of Alzheimer s Disease: State of the Art

Imaging of Alzheimer s Disease: State of the Art July 2015 Imaging of Alzheimer s Disease: State of the Art Neir Eshel, Harvard Medical School Year IV Outline Our patient Definition of dementia Alzheimer s disease Epidemiology Diagnosis Stages of progression

More information

The added value of the IWG-2 diagnostic criteria for Alzheimer s disease

The added value of the IWG-2 diagnostic criteria for Alzheimer s disease The added value of the IWG-2 diagnostic criteria for Alzheimer s disease Miami, January 2016 Bruno Dubois Head of the Dementia Research Center (IMMA) Director of INSERM Research Unit (ICM) Salpêtrière

More information

Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation

Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation 1. Reflection of Mild Cognitive Impairment (MCI) and Dementias by Molecular Imaging, PET

More information

Investigating the impact of midlife obesity on Alzheimer s disease (AD) pathology in a mouse model of AD

Investigating the impact of midlife obesity on Alzheimer s disease (AD) pathology in a mouse model of AD Brain@McGill Prize for Neuroscience Undergraduate Research Colleen Rollins Supervisor: Dr. Mallar Chakravarty Revised: August 8, 2017 Investigating the impact of midlife obesity on Alzheimer s disease

More information

2016 Programs & Information

2016 Programs & Information Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia

More information

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup Woollacott et al. Alzheimer's Research & Therapy (2018) 10:79 https://doi.org/10.1186/s13195-018-0405-8 RESEARCH Open Access Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by

More information

Stuttering Research. Vincent Gracco, PhD Haskins Laboratories

Stuttering Research. Vincent Gracco, PhD Haskins Laboratories Stuttering Research Vincent Gracco, PhD Haskins Laboratories Stuttering Developmental disorder occurs in 5% of children Spontaneous remission in approximately 70% of cases Approximately 1% of adults with

More information

Disease Modification in Schizophrenia: Overview of the Issues. ISCTM February 18 th 2014 Ravi Anand, MD Switzerland

Disease Modification in Schizophrenia: Overview of the Issues. ISCTM February 18 th 2014 Ravi Anand, MD Switzerland Disease Modification in Schizophrenia: Overview of the Issues ISCTM February 18 th 2014 Ravi Anand, MD Switzerland Need for a New Treatment Paradigm in Schizophrenia Sixty years after approval for the

More information

The Frontal Lobes. Anatomy of the Frontal Lobes. Anatomy of the Frontal Lobes 3/2/2011. Portrait: Losing Frontal-Lobe Functions. Readings: KW Ch.

The Frontal Lobes. Anatomy of the Frontal Lobes. Anatomy of the Frontal Lobes 3/2/2011. Portrait: Losing Frontal-Lobe Functions. Readings: KW Ch. The Frontal Lobes Readings: KW Ch. 16 Portrait: Losing Frontal-Lobe Functions E.L. Highly organized college professor Became disorganized, showed little emotion, and began to miss deadlines Scores on intelligence

More information

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge Introduction, use of imaging and current guidelines John O Brien Professor of Old Age Psychiatry University of Cambridge Why do we undertake brain imaging in AD and other dementias? Exclude other causes

More information

Early Onset Dementia From the background to the foreground

Early Onset Dementia From the background to the foreground Early Onset Dementia From the background to the foreground Dr Jeremy Isaacs Consultant Neurologist St George s Hospital Excellence in specialist and community healthcare Themes of my talk The early onset

More information

Changing diagnostic criteria for AD - Impact on Clinical trials

Changing diagnostic criteria for AD - Impact on Clinical trials Changing diagnostic criteria for AD - Impact on Clinical trials London, November 2014 Bruno Dubois Head of the Dementia Research Center (IMMA) Director of INSERM Research Unit (ICM) Salpêtrière Hospital

More information

doi: /brain/awr198 Brain 2011: 134;

doi: /brain/awr198 Brain 2011: 134; doi:10.1093/brain/awr198 Brain 2011: 134; 2565 2581 2565 BRAIN A JOURNAL OF NEUROLOGY Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration Jonathan D. Rohrer,

More information

The genetics and neuropathology of frontotemporal lobar degeneration

The genetics and neuropathology of frontotemporal lobar degeneration Acta Neuropathol (2012) 124:353 372 DOI 10.1007/s00401-012-1029-x REVIEW The genetics and neuropathology of frontotemporal lobar degeneration Anne Sieben Tim Van Langenhove Sebastiaan Engelborghs Jean-Jacques

More information

What is frontotemporal dementia?

What is frontotemporal dementia? What is frontotemporal dementia? Introduction Information in this introductory booklet is for anyone who wants to know more about frontotemporal dementia (FTD). This includes people living with FTD, their

More information

HIV Neurology Persistence of Cognitive Impairment Despite cart

HIV Neurology Persistence of Cognitive Impairment Despite cart HIV Neurology Persistence of Cognitive Impairment Despite cart Victor Valcour MD PhD Professor of Medicine Memory and Aging Center, Dept. of Neurology University of California San Francisco, USA 8 th International

More information

United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline

United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline REV 3/24/09 The UCNS Geriatric Neurology examination was established to determine the level of competence

More information

The ABCs of Dementia Diagnosis

The ABCs of Dementia Diagnosis The ABCs of Dementia Diagnosis Dr. Robin Heinrichs, Ph.D., ABPP Board Certified Clinical Neuropsychologist Associate Professor, Psychiatry & Behavioral Sciences Director of Neuropsychology Training What

More information

Dementia: A Comprehensive Update Neuroimaging, CSF, and genetic biomarkers in dementia

Dementia: A Comprehensive Update Neuroimaging, CSF, and genetic biomarkers in dementia Dementia: A Comprehensive Update 2016 Neuroimaging, CSF, and genetic biomarkers in dementia Bradford C. Dickerson, M.D. Associate Professor of Neurology, Harvard Medical School Departments of Neurology

More information

After the Diagnosis: Rehabilitation & Support Options for Mild Dementia

After the Diagnosis: Rehabilitation & Support Options for Mild Dementia After the Diagnosis: Rehabilitation & Support Options for Mild Dementia Dr. Toni Nicholls, Clinical Neuropsychologist Peronne Village, cottage #20, Worthing, Christ Church 621-2022 Say these aloud Dog

More information

Brain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1

Brain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1 Brain Advance Access published February 25, 2014 doi:10.1093/brain/awu024 Brain 2014: Page 1 of 17 1 BRAIN A JOURNAL OF NEUROLOGY Asymmetry and heterogeneity of Alzheimer s and frontotemporal pathology

More information

Presenter Disclosure Information. I have no financial relationships to disclose:

Presenter Disclosure Information. I have no financial relationships to disclose: Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois http://www.brain.northwestern.edu/dementia/ppa/index.html

More information

Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer s is the most common form of dementia.

Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer s is the most common form of dementia. CHAPTER 3 Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer s is the most common form of dementia. This incurable, degenerative, terminal disease

More information

The Person: Dementia Basics

The Person: Dementia Basics The Person: Dementia Basics Objectives 1. Discuss how expected age related changes in the brain might affect an individual's cognition and functioning 2. Discuss how changes in the brain due to Alzheimer

More information

Frontotemporal Dementia

Frontotemporal Dementia Frontotemporal Dementia clinical, genetic, and pathological heterogeneity Harro Seelaar The studies in this thesis were funded by: Stichting Dioraphte Hersenstichting Nederland Prinses Beatrix Fonds Nuts

More information

Myers Psychology for AP*

Myers Psychology for AP* Myers Psychology for AP* David G. Myers PowerPoint Presentation Slides by Kent Korek Germantown High School Worth Publishers, 2010 *AP is a trademark registered and/or owned by the College Board, which

More information

Nervous System. 1. What N.S. division controls skeletal muscles? 3. What kind of neuroglia myelinates axons in the PNS?

Nervous System. 1. What N.S. division controls skeletal muscles? 3. What kind of neuroglia myelinates axons in the PNS? . What N.S. division controls skeletal muscles? Nervous System SRS Review %. Central nervous system %. Peripheral nervous system %. Afferent division %. Somatic division %. Autonomic division %. Sympathetic

More information

Fact Sheet Alzheimer s disease

Fact Sheet Alzheimer s disease What is Alzheimer s disease Fact Sheet Alzheimer s disease Alzheimer s disease, AD, is a progressive brain disorder that gradually destroys a person s memory and ability to learn, reason, make judgements,

More information

Behavioural variant frontotemporal dementia with dominant gait disturbances case report

Behavioural variant frontotemporal dementia with dominant gait disturbances case report Psychiatr. Pol. 2016; 50(2): 329 336 PL ISSN 0033-2674 (PRINT), ISSN 2391-5854 (ONLINE) www.psychiatriapolska.pl DOI: http://dx.doi.org/10.12740/pp/58937 Behavioural variant frontotemporal dementia with

More information

Methods to examine brain activity associated with emotional states and traits

Methods to examine brain activity associated with emotional states and traits Methods to examine brain activity associated with emotional states and traits Brain electrical activity methods description and explanation of method state effects trait effects Positron emission tomography

More information

Modules 4 & 6. The Biology of Mind

Modules 4 & 6. The Biology of Mind Modules 4 & 6 The Biology of Mind 1 Neuron - 100 Billion - Communication System Glial cells Cell body (nucleus) Dendrites Axon Axon Terminals (terminal buttons) Synaptic cleft 3 4 Communication Within

More information

Neuroimaging for dementia diagnosis. Guidance from the London Dementia Clinical Network

Neuroimaging for dementia diagnosis. Guidance from the London Dementia Clinical Network Neuroimaging for dementia diagnosis Guidance from the London Dementia Clinical Network Authors Dr Stephen Orleans-Foli Consultant Psychiatrist, West London Mental Health NHS Trust Dr Jeremy Isaacs Consultant

More information

Visual Dysfunction in Alzheimer s Disease and Parkinson s Disease

Visual Dysfunction in Alzheimer s Disease and Parkinson s Disease Visual Dysfunction in Alzheimer s Disease and Parkinson s Disease Victoria S. Pelak, MD Professor of Neurology and Ophthalmology Divisions of Neuro-ophthalmology and Behavioral Neurology University of

More information

The neurolinguistic toolbox Jonathan R. Brennan. Introduction to Neurolinguistics, LSA2017 1

The neurolinguistic toolbox Jonathan R. Brennan. Introduction to Neurolinguistics, LSA2017 1 The neurolinguistic toolbox Jonathan R. Brennan Introduction to Neurolinguistics, LSA2017 1 Psycholinguistics / Neurolinguistics Happy Hour!!! Tuesdays 7/11, 7/18, 7/25 5:30-6:30 PM @ the Boone Center

More information

Unit 3: The Biological Bases of Behaviour

Unit 3: The Biological Bases of Behaviour Unit 3: The Biological Bases of Behaviour Section 1: Communication in the Nervous System Section 2: Organization in the Nervous System Section 3: Researching the Brain Section 4: The Brain Section 5: Cerebral

More information

New diagnostic criteria for Alzheimer s disease and mild cognitive impairment for the practical neurologist

New diagnostic criteria for Alzheimer s disease and mild cognitive impairment for the practical neurologist New diagnostic criteria for Alzheimer s disease and mild cognitive impairment for the practical neurologist Andrew E Budson, 1,2 Paul R Solomon 2,3 1 Center for Translational Cognitive Neuroscience, VA

More information